Cyclo Therapeutics Inc Asset Turnover Ratio (CYTH), as of third quarter 2024, current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Cyclo Therapeutics Inc   (NASDAQ: CYTH)
 

Cyclo Therapeutics Inc Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Due to the increase in investments during the third quarter 2024, Cyclo Therapeutics Inc 's asset turnover ratio sequentially decreased to 0.12 in the third quarter (Sep 30 2024), this is lower than usual.

Within sector 23 more businesses have achieved higher asset turnover ratio. While Asset turnover ratio total ranking has improved so far during the III Quarter 2024, to 2159, from total ranking in the second quarter 2024 at 2520.

Asset Turnover Ratio Definition


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

CYTH Asset Turnover Ratio (Sep 30 2024)
III. Quarter		 (Jun 30 2024)
II. Quarter		 (Mar 31 2024)
I. Quarter		 (Dec 31 2023)
IV. Quarter		 (Sep 30 2023)
III. Quarter
Y / Y Asset Change -5.85 % -2.63 % 60.95 % 214.28 % -34.54 %
Y / Y Revenue Change -52.82 % 5.11 % 32.83 % 66.7 % 9.58 %
Asset Turnover Ratio (TTM) 0.12 0.15 0.15 0.16 0.21
CYTH's Total Ranking # 2159 # 2520 # 1295 # 2925 # 3288
Seq. Asset Change 16.87 % -32.18 % -50.22 % 138.6 % 20.87 %
Seq. Revenue Change 89.9 % -39.19 % -34.99 % -37.15 % 323.06 %



Asset Turnover Ratio Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 24
Healthcare Sector # 206
Overall Market # 2159

Asset Turnover Ratio Statistics
High Average Low
51.79 19.18 4.31
(Dec 31 2016)   (Mar 31 2022)




CYTH Company Profile • Back to CYTH Efficiency Comparisons • Compare CYTH Asset Turnover Ratio to its Competitors



Companies with similar Asset Turnover Ratio for the quarter ending Sep 30 2024, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Sep 30 2024 Assets at quarter ending Sep 30 2024
Pulmonx Corporation  0.46 $ 77.865  Millions$ 170.598  Millions
23andme Holding Co  0.45 $ 191.889  Millions$ 422.590  Millions
Precision Biosciences Inc  0.45 $ 75.096  Millions$ 165.895  Millions
Catalent Inc   0.45 $ 4,422.000  Millions$ 9,832.000  Millions
Assertio Holdings inc   0.45 $ 125.763  Millions$ 280.957  Millions
Cervomed Inc   0.44 $ 13.194  Millions$ 30.011  Millions
Pacira Biosciences inc   0.44 $ 694.957  Millions$ 1,581.555  Millions
Ontrak Inc   0.44 $ 10.336  Millions$ 23.561  Millions
Pmgc Holdings Inc   0.44 $ 2.446  Millions$ 5.601  Millions
Pulmatrix Inc   0.44 $ 10.005  Millions$ 22.910  Millions
Skinhealth Systems Inc   0.44 $ 347.462  Millions$ 796.309  Millions
Bio techne Corp  0.43 $ 1,171.131  Millions$ 2,699.937  Millions
Boston Scientific Corporation  0.43 $ 15,911.000  Millions$ 36,747.750  Millions
Sangamo Therapeutics Inc   0.42 $ 52.291  Millions$ 124.640  Millions
Orthopediatrics Corp  0.42 $ 188.186  Millions$ 448.996  Millions
Cvrx inc   0.42 $ 46.444  Millions$ 111.264  Millions
Guardant Health Inc   0.42 $ 692.256  Millions$ 1,659.772  Millions
Avid Bioservices Inc   0.42 $ 150.538  Millions$ 362.477  Millions
Envista Holdings Corporation  0.42 $ 2,501.800  Millions$ 6,027.550  Millions
Exact Sciences Corporation  0.41 $ 2,721.924  Millions$ 6,567.380  Millions
Personalis Inc   0.41 $ 87.489  Millions$ 211.441  Millions
Surgery Partners Inc   0.41 $ 2,985.300  Millions$ 7,218.825  Millions
Fortress Biotech Inc   0.41 $ 62.501  Millions$ 151.235  Millions
Aurinia Pharmaceuticals Inc   0.41 $ 220.361  Millions$ 534.397  Millions
Hologic Inc  0.41 $ 3,623.200  Millions$ 8,807.500  Millions
Sonida Senior Living Inc   0.41 $ 278.115  Millions$ 676.555  Millions
Cytek Biosciences Inc   0.41 $ 200.452  Millions$ 490.369  Millions
Perrigo Company Plc  0.41 $ 4,390.800  Millions$ 10,762.475  Millions
Entrada Therapeutics Inc   0.41 $ 215.232  Millions$ 529.147  Millions
Teleflex Incorporated  0.40 $ 3,024.629  Millions$ 7,484.600  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.